DUBLIN–(BUSINESS WIRE)–The “Late Phase Study Trends and Market Outlook (2018-2022)” report has been added to ResearchAndMarkets.com’s offering.
Keeping up-to-date with the evolving pharmaceutical market is no easy task. The constant flow of newsletters hitting our inboxes is almost too much to wade through. But stay abreast of the market we must. To this end, this company publishes a series of Study Trends and Market Outlook reports aimed at providing our readers with a high-level view of the clinical development space.
For this report, 115 Late Phase decision-makers were surveyed to share their insights into where the Late Phase market is now and where it’s expected to head over the next four years.
What you will learn:
- 4-year examination of the industry’s Late Phase market dynamics, such as study volume and outsourced spend, analyzed by study design (Interventional studies and Observational research) and by study type (Post-marketing Safety studies, Health Economics and Outcomes Research, and Expanded Access studies)
- Average dollar value of outsourced Late Phase studies and how this varies by sponsor size
- Criteria sponsors use to select (and disqualify) clinical service providers
- Current and future predictions for Late Phase trends, including the use of technology, study complexity, and reliance on EMRs
How you can use this report:
- Gain an understanding of the key decision-makers within sponsor organizations to develop more targeted communications
- Learn the most desirable characteristics of a Late Phase service provider
- Discover trends in Late Phase technology use
For Pharma:
- Use the predictions of your peers to identify in what types of studies your competition is investing resources and understand how your company’s strategy compares to that of the industry.
For CROs:
- Utilize this information to ensure your capabilities and capacity are in line with the study types and volume that will be needed in the near future.
Major Topics:
Executive Summary
- Market Dynamics
- Provider Perceptions and Selection
Study Data
- Market Dynamics
- Provider Perceptions and Selection
- Late Phase Trends
Demographics
For more information about this report visit https://www.researchandmarkets.com/r/dvhf6x
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Clinical Trials